Mednow Commences Operation in Nova Scotia
Mednow Commences Operation in Nova Scotia
– On demand home delivery services now available in Halifax, the largest city in Atlantic Canada
– Mednow advances national coverage footprint, with operations in Ontario, BC and Nova Scotia
TORONTO–(BUSINESS WIRE)–Mednow Inc. (“Mednow” or the “Company”) (TSXV:MNOW; OTCQB:MDNWF), Canada’s on-demand virtual pharmacy, is pleased to announce it has received all necessary approvals for its pharmacy license from the Nova Scotia College of Pharmacists to expand its pharmacy operations in the province of Nova Scotia. With operations in Nova Scotia now established for on-demand home delivery services, Mednow.ca services Halifax, the largest city in Atlantic Canada, with same-day delivery. The Company now offers its digital pharmacy services through three fulfillment centres located in Ontario, British Columbia and Nova Scotia.
As previously reported on May 6, 2021, Mednow has secured a fulfillment center in Dartmouth, Nova Scotia, located adjacent to the Nova Scotia Health Care System. Mr. Patrick Murray joined Mednow to lead the growth of this operation as a pharmacist with over eight years of experience in community pharmacy of Halifax, most recently at Compass Pharmacies of Nova Scotia. The pharmacy market in Nova Scotia is unique, whereby pharmacists can be reimbursed by the province for prescribing for minor ailments, in additional to traditional prescriptions, which is consistent with Mednow’s holistic approach to pharmacy and healthcare.
“We are rapidly moving towards national coverage of the Canadian pharmacy market. A national footprint remains an important milestone for the growth of our institutional business and developing a comprehensive and digitally routed healthcare offering for Canadians. Nova Scotia brings us one step closer to achieving this goal and also provides an attractive population base for the roll out of our Medvisit and digital healthcare platforms,” said Karim Nassar, Chief Executive Officer.
About Mednow Inc.
Mednow is a healthcare technology company offering virtual access with exceptional care. Designed with access and quality care in mind, Mednow.ca provides virtual pharmacy services with convenience and through an interdisciplinary approach to healthcare that is focused on the patient experience. Pharmacy services include free at-home delivery of medications, a user-friendly interface for easy upload, transfer and refill of prescriptions, access to healthcare professionals through an intuitive chat experience, a specialized PillSmart™ system that packages prescriptions and vitamins by date and time, as well as access to telemedicine.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This release includes certain statements and information that constitute forward-looking information within the meaning of applicable Canadian securities laws, including statements regarding establishing a national footprint, and the benefits and results arising from a national presence. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as “intends,” “anticipates,” “it is expected,” or variations of such words and phrases, or statements that certain actions, events or results “may,” “could,” “should,” or “would” occur. Forward-looking statements are based on certain material assumptions and analyses made by management of the Company and the opinions and estimates of management of the Company as of the date of this press release, including that the transactions contemplated herein will close on the terms and timeline as anticipated by the management of the Company. Although the Company considers these assumptions to be reasonable based on information currently available to them, they may prove to be incorrect, and the forward-looking statements in this release are subject to numerous risks, uncertainties and other factors that may cause future results to differ materially from those expressed or implied in such forward-looking statements. Such risk factors may include, among others, the risk that the transactions contemplated herein will not close on the terms and timeline as anticipated by the management of the Company, or at all, the risk that the Company will not receive required regulatory approvals, the risk that the Company will be unable to complete its proposed activities or realize the benefits or results therefrom, and the other risks and uncertainties applicable to the Company and the business of the Company as set forth in the Company’s final long form prospectus dated February 26, 2021 and its other disclosure available under the Company’s profile at www.sedar.com. There can be no assurance that the transactions contemplated in this news release will complete. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not intend, and does not assume any obligation, to update these forward-looking statements or information to reflect changes in assumptions or changes in circumstances or any other events affections such statements and information other than as required by applicable laws, rules and regulations. We seek safe harbor.
Benjamin Ferdinand, Chief Financial Officer
Marc Charbin, Investor Relations